We further estimated the CYT activity, Teff IFN-gamma, MERK 18 signature, IPRES gene signature, EMT and TGFβ in MSI-H altered and MSI-H wt CRC patients (Figure 6A). This evidence concerns the gene TGFB1 and colorectal carcinoma.